Paloma Poza-Guedes
Hospital Universitario de Canarias
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paloma Poza-Guedes.
Contact Dermatitis | 2002
Paloma Poza-Guedes; Ruperto González-Pérez; Gabriela Canto
Female, 62 years old; following an osteosynthesis procedure she received prophylactically enoxaparin (ClexaneA) 40 mg a day, and 2 weeks later itchy infiltrated plaques appeared on the lower abdomen, persisting for 7 days. Heparin was interrupted on the 8th day due to an itchy rash spreading over the whole abdomen. Informed consent was obtained from all patients. Patch tests were carried out on their backs with undiluted preparations of 3 types of LMWH and UH (1000 IU/mL), with readings at 30 min [day (D)0], 48 and 96 h (D2 and D4). After a week, prick and intradermal (ID) tests were performed on their volar forearms (1/10–1/1 dilutions). 10 controls were included for all skin testing. Negative
American Journal of Rhinology & Allergy | 2011
Ruperto González-Pérez; Paloma Poza-Guedes; Ramón Vives-Conesa
Background The nasal provocation test (NPT) with lysine aspirin is a useful tool in the diagnosis of aspirin-exacerbated respiratory disease (AERD), previously reffered to as Samters disease. The aim of the present study focuses on methodological interventions to show the usefulness of the NPT with lysine aspirin in differentiating AERD patients from aspirin-tolerant asthma (ATA) patients to improve the diagnostic efficacy and minimize the risk for adverse reactions compared with the gold standard. Methods Thirty AERD patients comprised the active study group while the control group consisted of 25 ATA patients. A combination of objective nasal aerodynamic response (i.e., nasal inspiratory flow and nasal inspiratory resistance) was evaluated by active anterior rhinomanometry and the subjective clinical nasal and extranasal symptoms (including forced expiratory volume) were monitored throughout the challenge. Results Fifty-five NPTs were successfully completed: sensitivity, 87%; specificity, 100%; positive predictive value, 100%; negative predictive value, 86%; global efficacy, 92.72%. No severe adverse reactions were recorded. Conclusion The present NPT with lysine aspirin proved to be a safe, efficient, and a timesaving method in the diagnosis of patients with AERD, even in those with severe rhinitis–rhinosinusitis and/or recurrent nasal polyposis.
The Journal of Allergy and Clinical Immunology | 2002
Ruperto González-Pérez; Ramon Vives; Paloma Poza-Guedes; Rosa Merchán; Stefan Cimbollek; Julia Rodriguez
The Journal of Allergy and Clinical Immunology | 2002
Julia Rodriguez; Gemma Izquierdo; Paloma Poza-Guedes; Paloma Campo; Pilar Daroca; Jesus F. Crespo
The Journal of Allergy and Clinical Immunology | 2012
Ruperto González-Pérez; Paloma Poza-Guedes; Victor Matheu; V. Iraola; Javier Iglesias-Souto; Inmaculada Sánchez-Machín
The Journal of Allergy and Clinical Immunology | 2008
Ruperto González-Pérez; Paloma Poza-Guedes; Ramón Vives-Conesa
The Journal of Allergy and Clinical Immunology | 2008
Ruperto González-Pérez; Paloma Poza-Guedes; Victor Matheu; Inmaculada Sánchez-Machín; Javier Iglesias-Souto; E. Rodríguez-Plata; José Carlos García-Robaina
The Journal of Allergy and Clinical Immunology | 2018
Ruperto González-Pérez; Fernando Pineda; Paloma Poza-Guedes; Victor Matheu; Inmaculada Sánchez-Machín
The Journal of Allergy and Clinical Immunology | 2018
Fernando Pineda; Ruperto González-Pérez; Paloma Poza-Guedes; Miriam Castillo; Inmaculada Sánchez-Machín; Victor Matheu
The Journal of Allergy and Clinical Immunology | 2016
Victor Matheu; Paloma Poza-Guedes; Inmaculada Sánchez-Machín; Yvelise Barrios; Andres Franco; Ruperto González